Personalizing Prevention Strategies in Endometrial Cancer

子宫内膜癌的个性化预防策略

基本信息

  • 批准号:
    421784
  • 负责人:
  • 金额:
    $ 7.29万
  • 依托单位:
  • 依托单位国家:
    加拿大
  • 项目类别:
    Operating Grants
  • 财政年份:
    2019
  • 资助国家:
    加拿大
  • 起止时间:
    2019-10-01 至 2020-10-01
  • 项目状态:
    已结题

项目摘要

Cancer of the uterus, also known as endometrial cancer, is the most common gynecological malignancy in the developed world. Many risk factors associated with endometrial cancer, such as obesity, can be modified; this provides a unique opportunity for the
子宫癌,又称子宫内膜癌,是发达国家最常见的妇科恶性肿瘤。许多与子宫内膜癌相关的风险因素,如肥胖,都可以改变;这为

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Talhouk Aline其他文献

Talhouk Aline的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Talhouk Aline', 18)}}的其他基金

Digital self-tracking and self-testing for early detection of endometrial cancer
数字化自我跟踪和自我测试,用于子宫内膜癌的早期发现
  • 批准号:
    461578
  • 财政年份:
    2022
  • 资助金额:
    $ 7.29万
  • 项目类别:
    Operating Grants
Improving endometrial cancer risk prediction by including genetic, environmental, and temporal exposures
通过包括遗传、环境和时间暴露来改善子宫内膜癌风险预测
  • 批准号:
    473461
  • 财政年份:
    2022
  • 资助金额:
    $ 7.29万
  • 项目类别:
    Operating Grants
Digital self-tracking for early detection and prevention of endometrial cancer during reproductive aging
数字自我跟踪用于生殖衰老期间子宫内膜癌的早期检测和预防
  • 批准号:
    455983
  • 财政年份:
    2021
  • 资助金额:
    $ 7.29万
  • 项目类别:
    Operating Grants
RESToRE – Risk Evaluation and Screening to Tailor prevention and Reduce the incidence of Endometrial cancer
RESTORE — 风险评估和筛查以定制预防并降低子宫内膜癌的发病率
  • 批准号:
    460392
  • 财政年份:
    2021
  • 资助金额:
    $ 7.29万
  • 项目类别:
    Operating Grants
Pre-operative Risk Stratification in Endometrial Cancer to Inform Surgical Management
子宫内膜癌术前风险分层为手术管理提供信息
  • 批准号:
    409627
  • 财政年份:
    2019
  • 资助金额:
    $ 7.29万
  • 项目类别:
    Operating Grants

相似海外基金

A novel mechanism of menopause-induced endometrial cancer that develops through functional loss of the helicase family
更年期诱发子宫内膜癌的新机制是通过解旋酶家族功能丧失而发生的
  • 批准号:
    24K19688
  • 财政年份:
    2024
  • 资助金额:
    $ 7.29万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Mechanisms of tamoxifen-associated endometrial cancer risk
他莫昔芬相关子宫内膜癌风险的机制
  • 批准号:
    10650054
  • 财政年份:
    2023
  • 资助金额:
    $ 7.29万
  • 项目类别:
Project 1: Targeting HSPA Proteins in Advanced and Recurrent Endometrial Cancer Therapy
项目 1:针对晚期和复发性子宫内膜癌治疗中的 HSPA 蛋白
  • 批准号:
    10711636
  • 财政年份:
    2023
  • 资助金额:
    $ 7.29万
  • 项目类别:
Detection of imaging features related to node metastasis in uterine endometrial cancer
子宫内膜癌淋巴结转移相关影像学特征的检测
  • 批准号:
    23K07209
  • 财政年份:
    2023
  • 资助金额:
    $ 7.29万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Development of new endocrine therapy based on genomic classification for endometrial cancer
基于子宫内膜癌基因组分类开发新内分泌疗法
  • 批准号:
    23K15818
  • 财政年份:
    2023
  • 资助金额:
    $ 7.29万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Claims-based measures of care coordination and long-term health among older women with endometrial cancer
患有子宫内膜癌的老年妇女的基于索赔的护理协调和长期健康措施
  • 批准号:
    10579456
  • 财政年份:
    2023
  • 资助金额:
    $ 7.29万
  • 项目类别:
Elucidation of molecular mechanisms involved in the diversity and plasticity of endometrial cancer stem cells and development of novel multifaceted therapies
阐明子宫内膜癌干细胞多样性和可塑性的分子机制并开发新型多方面疗法
  • 批准号:
    23H03044
  • 财政年份:
    2023
  • 资助金额:
    $ 7.29万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Endometrial Cancer Survival and Survivorship among Latinas in California: A Mixed Methods Study
加利福尼亚州子宫内膜癌生存率和拉丁裔生存率:一项混合方法研究
  • 批准号:
    10461655
  • 财政年份:
    2023
  • 资助金额:
    $ 7.29万
  • 项目类别:
Establishment of predictive factor of oncologic / pregnancy outcome on fertility sparing treatment for young patients with endometrial cancer
年轻子宫内膜癌患者保留生育治疗的肿瘤/妊娠结局预测因素的建立
  • 批准号:
    23K08808
  • 财政年份:
    2023
  • 资助金额:
    $ 7.29万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Combination Therapies Targeting Insulin Signaling in Endometrial Cancer
子宫内膜癌中针对胰岛素信号传导的联合疗法
  • 批准号:
    10637167
  • 财政年份:
    2023
  • 资助金额:
    $ 7.29万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了